An Open-Label Phase I/IIa Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients
Phase of Trial: Phase I/II
Latest Information Update: 27 Nov 2017
At a glance
- Drugs Vardenafil (Primary)
- Indications Erectile dysfunction
- Focus Adverse reactions; Therapeutic Use
- Sponsors Tritech
- 21 Nov 2017 Planned primary completion date changed from 31 Aug 2017 to 31 Jan 2018.
- 28 Jun 2017 Status changed from active, no longer recruiting to recruiting.
- 11 May 2017 Status changed from recruiting to active, no longer recruiting.